NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SATT AxLR

SATT AxLR

Montpellieraxlr.com

Overview

SATT AxLR is a technology transfer accelerator based in France that funds and develops innovations from academic research in sectors including health, biotechnology, agronomy, chemistry, and IT.

Year Founded

2012

Portfolio Companies

7

Website

axlr.com

Investments

SATT AxLR investments
CompanyDateStageLead
Nervosave TherapeuticsNov 2025SeedLead
TerratisDec 2024Early FundingCo-investor
SPIMA TherapeuticsSep 2024SeedLead
Bliss EcosprayJan 2021Pre SeedCo-investor
IPRASENSEJul 2019AcceleratorLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMontpellier
Year Founded2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.